Phosphate Binders in CKD: ‟New Kids on the Block”

Autor/innen

  • Muhammad Umair Afzal
  • Shafeeq Cheema Jinah Hospital, Lahore

DOI:

https://doi.org/10.53778/pjkd31089

Schlagwörter:

hyperphosphatemia, mineral bone disease, sevelamer, ferric sitrate, lanthanum, sucro ferricoxyhydroxide

Abstract

Phosphate control is essential component of dietary and medical management of chronic kidney disease (CKD) patients. Hyperphosphatemia has a significant effect on morbidity and mortality of CKD patients. This review takes us through the different older and newer medications available for management of hyperphosphatemia.

Veröffentlicht

2021-02-05

Zitationsvorschlag

Phosphate Binders in CKD: ‟New Kids on the Block”. (2021). Pakistan Journal of Kidney Diseases, 3(10). https://doi.org/10.53778/pjkd31089